Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of Enzira influenza vaccine immunogenicity and safety in adults and older adults (2006/2007 Northern Hemisphere season)
2006-002068-25Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity according to CPMP/BWP/214/96 criteria and Safety of Enzira in adults and older adults. Started Apr 2006; status: completed.
02
Drugs
omeprazole
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002068-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002068-25.